Literature DB >> 2405683

Changes in the extracellular matrix of the human optic nerve head in primary open-angle glaucoma.

M R Hernandez1, W M Andrzejewska, A H Neufeld.   

Abstract

Using immunofluorescent staining, we were able to characterize the changes in composition and distribution of the macromolecules making up the extracellular matrix of the lamina cribrosa of the glaucomatous human optic nerve head. In tissue adjacent to the glaucomatous cups, there was marked disorganization and loss of fibers of elastin within the cores of the cribriform plates. Collagen type VI, normally sparse, increased in quantity considerably throughout the lamina cribrosa in glaucomatous eyes with all degrees of damage. Collagen type IV and other basement membrane macromolecules appeared to extend into nerve bundles, presumably filling in spaces previously occupied by nerves. There was no appreciable change in the postlaminar region, which indicates the specificity of the extracellular matrix changes in the lamina cribrosa. Our results indicate that changes in the extracellular matrix play an important role in the progression of the glaucomatous process and may be a causative agent of the disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2405683     DOI: 10.1016/s0002-9394(14)75984-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  64 in total

Review 1.  Ganglion cell death in glaucoma: what do we really know?

Authors:  N N Osborne; J P Wood; G Chidlow; J H Bae; J Melena; M S Nash
Journal:  Br J Ophthalmol       Date:  1999-08       Impact factor: 4.638

2.  Extracellular matrix changes of the optic nerve lamina cribrosa in monkey eyes with experimentally chronic glaucoma.

Authors:  T Fukuchi; S Sawaguchi; H Hara; M Shirakashi; K Iwata
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

3.  Proteomics analyses of human optic nerve head astrocytes following biomechanical strain.

Authors:  Ronan S Rogers; Moyez Dharsee; Suzanne Ackloo; Jeremy M Sivak; John G Flanagan
Journal:  Mol Cell Proteomics       Date:  2011-11-29       Impact factor: 5.911

4.  Expansions of the neurovascular scleral canal and contained optic nerve occur early in the hypertonic saline rat experimental glaucoma model.

Authors:  Marta Pazos; Hongli Yang; Stuart K Gardiner; William O Cepurna; Elaine C Johnson; John C Morrison; Claude F Burgoyne
Journal:  Exp Eye Res       Date:  2015-10-22       Impact factor: 3.467

5.  Involvement of EphB/Ephrin-B signaling in axonal survival in mouse experimental glaucoma.

Authors:  Christine T Fu; David Sretavan
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-05       Impact factor: 4.799

6.  Adaptive optics scanning laser ophthalmoscopy for in vivo imaging of lamina cribrosa.

Authors:  Abhiram S Vilupuru; Nalini V Rangaswamy; Laura J Frishman; Earl L Smith; Ronald S Harwerth; Austin Roorda
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2007-05       Impact factor: 2.129

7.  Remodeling of the connective tissue microarchitecture of the lamina cribrosa in early experimental glaucoma.

Authors:  Michael D Roberts; Vicente Grau; Jonathan Grimm; Juan Reynaud; Anthony J Bellezza; Claude F Burgoyne; J Crawford Downs
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-20       Impact factor: 4.799

8.  Integrins in the optic nerve head: potential roles in glaucomatous optic neuropathy (an American Ophthalmological Society thesis).

Authors:  John C Morrison
Journal:  Trans Am Ophthalmol Soc       Date:  2006

Review 9.  Life under pressure: The role of ocular cribriform cells in preventing glaucoma.

Authors:  Jayter S Paula; Colm O'Brien; W Daniel Stamer
Journal:  Exp Eye Res       Date:  2016-08-25       Impact factor: 3.467

Review 10.  Development of diagnostic and treatment strategies for glaucoma through understanding and modification of scleral and lamina cribrosa connective tissue.

Authors:  Harry A Quigley; Frances E Cone
Journal:  Cell Tissue Res       Date:  2013-03-28       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.